Prostaglandins and inflammation: receptor/cyclase coupling as an explanation of why PGEs and PGI2 inhibit functions of inflammatory cells.
D000262:Adenylyl Cyclases / Q000378:metabolism; D000818:Animals; D000242:Cyclic AMP / Q000378:metabolism; D004487:Edema / Q000209:etiology; D011464:Epoprostenol / Q000494:pharmacology*; D005334:Fever / Q000503:physiopathology; D006098:Granulocytes / Q000378:metabolism; D006801:Humans; D007249:Inflammation / Q000503:physiopathology*; D008247:Lysosomes / Q000201:enzymology; D008264:Macrophages / Q000187:drug effects; D009504:Neutrophils / Q000187:drug effects*; D010146:Pain / Q000503:physiopathology; D011453:Prostaglandins / Q000494:pharmacology* / Q000502:physiology*; D011458:Prostaglandins E / Q000494:pharmacology*; D011982:Receptors, Prostaglandin / Q000502:physiology; D014664:Vasodilation / Q000187:drug effects
D011453:Prostaglandins; D011458:Prostaglandins E; D011982:Receptors, Prostaglandin; D011464:Epoprostenol; D000242:Cyclic AMP; D000262:Adenylyl Cyclases